UniProt ID | EXOC1_HUMAN | |
---|---|---|
UniProt AC | Q9NV70 | |
Protein Name | Exocyst complex component 1 | |
Gene Name | EXOC1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 894 | |
Subcellular Localization | Midbody, Midbody ring . Cytoplasm . Cytoplasm, perinuclear region . Colocalizes with CNTRL/centriolin at the midbody ring. | |
Protein Description | Component of the exocyst complex involved in the docking of exocytic vesicles with fusion sites on the plasma membrane.; (Microbial infection) Has an antiviral effect against flaviviruses by affecting viral RNA transcription and translation through the sequestration of elongation factor 1-alpha (EEF1A1). This results in decreased viral RNA synthesis and decreased viral protein translation.. | |
Protein Sequence | MTAIKHALQRDIFTPNDERLLSIVNVCKAGKKKKNCFLCATVTTERPVQVKVVKVKKSDKGDFYKRQIAWALRDLAVVDAKDAIKENPEFDLHFEKIYKWVASSTAEKNAFISCIWKLNQRYLRKKIDFVNVSSQLLEESVPSGENQSVTGGDEEVVDEYQELNAREEQDIEIMMEGCEYAISNAEAFAEKLSRELQVLDGANIQSIMASEKQVNILMKLLDEALKEVDQIELKLSSYEEMLQSVKEQMDQISESNHLIHLSNTNNVKLLSEIEFLVNHMDLAKGHIKALQEGDLASSRGIEACTNAADALLQCMNVALRPGHDLLLAVKQQQQRFSDLRELFARRLASHLNNVFVQQGHDQSSTLAQHSVELTLPNHHPFHRDLLRYAKLMEWLKSTDYGKYEGLTKNYMDYLSRLYEREIKDFFEVAKIKMTGTTKESKKFATLPRKESAVKQETESLHGSSGKLTGSTSSLNKLSVQSSGNRRSQSSSLLDMGNMSASDLDVADRTKFDKIFEQVLSELEPLCLAEQDFISKFFKLQQHQSMPGTMAEAEDLDGGTLSRQHNCGTPLPVSSEKDMIRQMMIKIFRCIEPELNNLIALGDKIDSFNSLYMLVKMSHHVWTAQNVDPASFLSTTLGNVLVTVKRNFDKCISNQIRQMEEVKISKKSKVGILPFVAEFEEFAGLAESIFKNAERRGDLDKAYTKLIRGVFVNVEKVANESQKTPRDVVMMENFHHIFATLSRLKISCLEAEKKEAKQKYTDHLQSYVIYSLGQPLEKLNHFFEGVEARVAQGIREEEVSYQLAFNKQELRKVIKEYPGKEVKKGLDNLYKKVDKHLCEEENLLQVVWHSMQDEFIRQYKHFEGLIARCYPGSGVTMEFTIQDILDYCSSIAQSH | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Acetylation | ---MTAIKHALQRDI ---CCHHHHHHHCCC | 21.99 | 19608861 | |
5 | Malonylation | ---MTAIKHALQRDI ---CCHHHHHHHCCC | 21.99 | 26320211 | |
22 | Phosphorylation | PNDERLLSIVNVCKA CCHHHHHHHHHHHHC | 29.14 | 28122231 | |
28 | Acetylation | LSIVNVCKAGKKKKN HHHHHHHHCCCCCCC | 56.76 | 25953088 | |
28 | Malonylation | LSIVNVCKAGKKKKN HHHHHHHHCCCCCCC | 56.76 | 26320211 | |
34 | Malonylation | CKAGKKKKNCFLCAT HHCCCCCCCEEEEEE | 68.76 | 26320211 | |
41 | Phosphorylation | KNCFLCATVTTERPV CCEEEEEEECCCCCE | 19.86 | 20068231 | |
43 | Phosphorylation | CFLCATVTTERPVQV EEEEEEECCCCCEEE | 20.70 | 20068231 | |
44 | Phosphorylation | FLCATVTTERPVQVK EEEEEECCCCCEEEE | 26.17 | 20068231 | |
85 | Ubiquitination | VDAKDAIKENPEFDL ECHHHHHHHCCCCCC | 53.83 | - | |
117 | Acetylation | AFISCIWKLNQRYLR HHHHHHHHHHHHHHH | 20.04 | 25953088 | |
160 | Phosphorylation | DEEVVDEYQELNARE CHHHHHHHHHHCHHH | 11.65 | 27642862 | |
288 (in isoform 2) | Ubiquitination | - | 37.05 | 21906983 | |
288 (in isoform 1) | Ubiquitination | - | 37.05 | 21906983 | |
288 | Malonylation | DLAKGHIKALQEGDL HHHHHHHHHHHHCCC | 37.05 | 26320211 | |
288 | Ubiquitination | DLAKGHIKALQEGDL HHHHHHHHHHHHCCC | 37.05 | - | |
297 | Phosphorylation | LQEGDLASSRGIEAC HHHCCCCHHHCHHHH | 28.06 | 29255136 | |
298 | Phosphorylation | QEGDLASSRGIEACT HHCCCCHHHCHHHHH | 28.99 | 29255136 | |
337 | Phosphorylation | KQQQQRFSDLRELFA HHHHHHHHHHHHHHH | 37.61 | 24719451 | |
397 | Phosphorylation | KLMEWLKSTDYGKYE HHHHHHHCCCCCCCC | 25.08 | 20068231 | |
398 | Phosphorylation | LMEWLKSTDYGKYEG HHHHHHCCCCCCCCC | 31.49 | 20068231 | |
400 | Phosphorylation | EWLKSTDYGKYEGLT HHHHCCCCCCCCCCC | 18.66 | 20068231 | |
402 | Ubiquitination | LKSTDYGKYEGLTKN HHCCCCCCCCCCCHH | 33.62 | - | |
441 | Ubiquitination | TGTTKESKKFATLPR ECCCHHHHCCCCCCC | 53.66 | - | |
445 | Phosphorylation | KESKKFATLPRKESA HHHHCCCCCCCCHHH | 40.19 | 28348404 | |
448 (in isoform 2) | Phosphorylation | - | 59.49 | 30266825 | |
449 (in isoform 2) | Phosphorylation | - | 54.82 | 30266825 | |
451 | Phosphorylation | ATLPRKESAVKQETE CCCCCCHHHHHHHHH | 41.20 | 29496963 | |
453 (in isoform 2) | Phosphorylation | - | 10.28 | 26434776 | |
455 (in isoform 2) | Phosphorylation | - | 57.13 | 25849741 | |
456 (in isoform 2) | Phosphorylation | - | 49.15 | 26434776 | |
457 (in isoform 2) | Phosphorylation | - | 28.51 | 25849741 | |
457 | Phosphorylation | ESAVKQETESLHGSS HHHHHHHHHHHCCCC | 28.51 | 28985074 | |
458 (in isoform 2) | Phosphorylation | - | 51.02 | 25849741 | |
459 | Phosphorylation | AVKQETESLHGSSGK HHHHHHHHHCCCCCE | 32.84 | 25849741 | |
463 | Phosphorylation | ETESLHGSSGKLTGS HHHHHCCCCCEECCC | 25.77 | 25849741 | |
464 | Phosphorylation | TESLHGSSGKLTGST HHHHCCCCCEECCCC | 44.53 | 25849741 | |
468 | Phosphorylation | HGSSGKLTGSTSSLN CCCCCEECCCCHHHC | 32.35 | 30266825 | |
470 | Phosphorylation | SSGKLTGSTSSLNKL CCCEECCCCHHHCCE | 21.63 | 29255136 | |
471 | Phosphorylation | SGKLTGSTSSLNKLS CCEECCCCHHHCCEE | 24.55 | 29255136 | |
472 | Phosphorylation | GKLTGSTSSLNKLSV CEECCCCHHHCCEEE | 34.23 | 29255136 | |
473 | Phosphorylation | KLTGSTSSLNKLSVQ EECCCCHHHCCEEEC | 35.73 | 29255136 | |
478 | Phosphorylation | TSSLNKLSVQSSGNR CHHHCCEEECCCCCC | 21.51 | 28152594 | |
481 | Phosphorylation | LNKLSVQSSGNRRSQ HCCEEECCCCCCCCC | 37.75 | 30266825 | |
482 | Phosphorylation | NKLSVQSSGNRRSQS CCEEECCCCCCCCCC | 24.01 | 30266825 | |
487 | Phosphorylation | QSSGNRRSQSSSLLD CCCCCCCCCCCCCHH | 31.04 | 25159151 | |
489 | Phosphorylation | SGNRRSQSSSLLDMG CCCCCCCCCCCHHCC | 24.12 | 23401153 | |
490 | Phosphorylation | GNRRSQSSSLLDMGN CCCCCCCCCCHHCCC | 19.85 | 25159151 | |
491 | Phosphorylation | NRRSQSSSLLDMGNM CCCCCCCCCHHCCCC | 37.89 | 25159151 | |
499 | Phosphorylation | LLDMGNMSASDLDVA CHHCCCCCHHHCCHH | 28.72 | 30266825 | |
501 | Phosphorylation | DMGNMSASDLDVADR HCCCCCHHHCCHHCH | 31.25 | 25159151 | |
509 | Phosphorylation | DLDVADRTKFDKIFE HCCHHCHHHHHHHHH | 36.29 | 23403867 | |
544 | Phosphorylation | FKLQQHQSMPGTMAE HHHHHCCCCCCCCCE | 25.48 | 29255136 | |
548 | Phosphorylation | QHQSMPGTMAEAEDL HCCCCCCCCCEEECC | 13.82 | 29255136 | |
559 | Phosphorylation | AEDLDGGTLSRQHNC EECCCCCCCCCCCCC | 27.39 | 29255136 | |
561 | Phosphorylation | DLDGGTLSRQHNCGT CCCCCCCCCCCCCCC | 29.72 | 29255136 | |
568 | Phosphorylation | SRQHNCGTPLPVSSE CCCCCCCCCCCCCCH | 24.69 | 26657352 | |
609 | Phosphorylation | DKIDSFNSLYMLVKM CHHHHHHHHHHHHHH | 20.90 | 23663014 | |
611 | Phosphorylation | IDSFNSLYMLVKMSH HHHHHHHHHHHHHHC | 6.55 | 23663014 | |
635 | Phosphorylation | PASFLSTTLGNVLVT HHHHHHHCCCCHHHE | 29.32 | 24532841 | |
642 | Phosphorylation | TLGNVLVTVKRNFDK CCCCHHHEEECCHHH | 19.02 | 24532841 | |
649 | Ubiquitination | TVKRNFDKCISNQIR EEECCHHHHHHHHHH | 29.36 | - | |
687 | Phosphorylation | EFAGLAESIFKNAER HHHHHHHHHHHHHHH | 27.93 | 24719451 | |
700 | Acetylation | ERRGDLDKAYTKLIR HHHCCHHHHHHHHHH | 51.06 | 12432695 | |
702 | Phosphorylation | RGDLDKAYTKLIRGV HCCHHHHHHHHHHHH | 15.33 | 22817900 | |
703 | Phosphorylation | GDLDKAYTKLIRGVF CCHHHHHHHHHHHHC | 25.00 | 21955146 | |
704 | Acetylation | DLDKAYTKLIRGVFV CHHHHHHHHHHHHCC | 29.28 | 25953088 | |
704 | Malonylation | DLDKAYTKLIRGVFV CHHHHHHHHHHHHCC | 29.28 | 26320211 | |
722 | Acetylation | KVANESQKTPRDVVM HHCCCCCCCHHHEEH | 70.54 | 25953088 | |
769 | Phosphorylation | HLQSYVIYSLGQPLE HHHHHHHHHCCCCHH | 6.44 | 22817900 | |
799 | Phosphorylation | GIREEEVSYQLAFNK CCCHHHHHHHHHCCH | 15.50 | - | |
800 | Phosphorylation | IREEEVSYQLAFNKQ CCHHHHHHHHHCCHH | 16.84 | 28796482 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of EXOC1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of EXOC1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of EXOC1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-5, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-487 AND SER-501, ANDMASS SPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-470 AND THR-471, ANDMASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-471 AND SER-473, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-470 AND SER-473, ANDMASS SPECTROMETRY. |